Möchten Sie immer auf dem neuesten Stand bleiben?

NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s leading issuers of crypto exchange-traded funds (ETFs), today announced it has been named to the Fortune Crypto 100 list, a...

Ad hoc announcement pursuant to Art. 53 LR FORTITUDE study met primary and key secondary endpoints of reduction in KHDC1L and creatine kinase levels, with safety profile consistent with previous...

Filing acceptance is based on the phase III Alliance ATOMIC study showing Tecentriq plus chemotherapy reduced recurrence or death risk by 50% versus chemotherapy alone1Nearly one in three patients...

Press Release dsm-firmenich receives FDA approval on PARSOL® Shield, a new sun protection ingredient for the U.S. Kaiseraugst (Switzerland), Maastricht (Netherlands), June 10, 2026 dsm-firmenich,...

WISeKey’s SEALCOIN Subsidiary Accelerates Space-Based Blockchain Infrastructure Following Strategic $4 Million Investment Commitment New Funding from The Hashgraph Group and WISeKey Supports...

Ad hoc announcement pursuant to Art. 53 LR Senior secured term loan of up to CHF 250 million with a 5‑year maturity at a fixed 7% interest rateFirst tranche will fully refinance the existing New...

SIKA OPENS STATE-OF-THE-ART PRODUCTION AND CONCRETE SERVICE HUB IN THE BENELUX REGION Sika expands its production and innovation capabilities in Europe by commissioning a new plant and technical...

SIKA ERÖFFNET HOCHMODERNES PRODUKTIONS- UND BETON-SERVICE-ZENTRUM IN DER BENELUX-REGIONSika baut ihre Produktions- und Innovationskapazitäten in Europa aus und nimmt im belgischen Ham ein neues Werk...

Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), June 9, 2026 dsm-firmenich, innovators in...

Results from Rhapsido (remibrutinib) pivotal Phase III RemIND trial, the largest study in chronic inducible urticaria, to be highlighted in late-breaker oral presentationNew Phase IIIb REMIXED...